Silence Therapeutics Prices Upsized $175 Million Offering After Positive Divesiran Data

Company: Silence Therapeutics · Event Type: Public Offering · Product/Asset: Divesiran / siRNA Pipeline · Offering Size: ~$175M Gross Proceeds · Priced: August 11, 2026 · Closed: August 13, 2026 Summary Silence Therapeutics priced an underwritten public offering of American Depositary Shares expected to generate…